Profile
Lisa Nibauer worked as the President-Diagnostics at OraSure Technologies, Inc. from 2021 to 2022.
Prior to that, she was the VP-Global Medication Delivery Solutions at Becton Dickinson AG.
Ms. Nibauer completed her undergraduate degree at Lehigh University and earned an MBA from UCLA Anderson School of Management.
Former positions of Lisa Nibauer
| Companies | Position | End |
|---|---|---|
| ORASURE TECHNOLOGIES, INC. | Corporate Officer/Principal | 10/11/2022 |
Becton Dickinson AG
 Becton Dickinson AG Medical DistributorsDistribution Services Becton Dickinson AG engages in the development, manufacture, and distribution of single-use medical devices, equipment, antibodies, reagents, and diagnostics. It operates through the following segments: BD Medical, BD Diagnostics, and BD Biosciences. The BD Medical segment manufactures single-use medical devices such as syringes and cannulas. The BD Diagnostics segment specializes in the safe collection and transport of diagnostic samples and offers devices and reagents for the accurate diagnosis of infectious diseases, nosocomial infections, and cancer. The BD Biosciences segments provides solutions to bioscientists, clinical researchers, and physicians working in the areas of basic and drug discovery, vaccine development, biopharmaceutical production, and structured treatment programs. The company was founded on October 27, 1972 and is headquartered in Allschwil, Switzerland. | Corporate Officer/Principal | - |
Training of Lisa Nibauer
| Lehigh University | Undergraduate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ORASURE TECHNOLOGIES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Becton Dickinson AG
Becton Dickinson AG Medical DistributorsDistribution Services Becton Dickinson AG engages in the development, manufacture, and distribution of single-use medical devices, equipment, antibodies, reagents, and diagnostics. It operates through the following segments: BD Medical, BD Diagnostics, and BD Biosciences. The BD Medical segment manufactures single-use medical devices such as syringes and cannulas. The BD Diagnostics segment specializes in the safe collection and transport of diagnostic samples and offers devices and reagents for the accurate diagnosis of infectious diseases, nosocomial infections, and cancer. The BD Biosciences segments provides solutions to bioscientists, clinical researchers, and physicians working in the areas of basic and drug discovery, vaccine development, biopharmaceutical production, and structured treatment programs. The company was founded on October 27, 1972 and is headquartered in Allschwil, Switzerland. | Distribution Services |
- Stock Market
- Insiders
- Lisa Nibauer
